Genotypes of the circulating rotavirus strains in the seven prevaccine seasons from September 2000 to August 2007 in South Korea

Clinical Microbiology and Infection

Volumn 17, Issue 2, 2011, Pages 232-235

  Jeong, H S ^a   Lee, K B ^a   Jeong, A Y ^a   Jo, M Y ^a   Jung, S Y ^a   Ahn, J H ^a   Jee, Y ^a   Kim, J ^b   Cheon, D S ^a  

^a Korea Centers for Disease Control and Prevention   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Gastroenteritis; Genotype; Group A rotavirus; Surveillance; Vaccination

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; DRUG EFFICACY; GENOTYPE; HEALTH SURVEY; HUMAN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; ROTAVIRUS; SOUTH KOREA; VIRUS DETECTION; VIRUS STRAIN;

ROTAVIRUS; ROTAVIRUS A;

EID: 78751634672     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03232.x     Document Type: Article

References (16)

1. Estes MK. Rotaviruses and their replication. In: Knipe D, Howley P, editors, Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins, 2007; 1747-1785.
2. Parashar UD, Glass RI. Public health. Progress toward rotavirus vaccines. Science 2006; 312: 851-852.
3. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9: 565-572.
4. Clark HF, Offit PA, Ellis RW et al. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis 1996; 174: S73-S80.
5. Gentsch JR, Hull JJ, Teel EN et al. G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis 2009; 200: S99-S105.
6. Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 2004; 31: 259-265.
7. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15: 29-56.
8. Bányai K, Bogdán A, Kisfali P et al. Emergence of serotype G12 rotaviruses, Hungary. Emerg Infect Dis 2007; 13: 916-919.
9. Rahman M, Matthijnssens J, Yang X et al. Evolutionary history and global spread of the emerging G12 human rotaviruses. J Virol 2007; 81: 2382-2390.
10. Lee SY, Hong SK, Lee SG et al. Human rotavirus genotypes in hospitalized children, South Korea, April 2005 to March 2007. Vaccine 2009; 27 (Suppl. 5): F97-F101.
11. Kim JS, Kang JO, Cho SC et al. Epidemiological profile of rotavirus infection in the Republic of Korea: results from prospective surveillance in the Jeongeub district, 1 July 2002 through 30 June 2004. J Infect Dis 2005; 192 (Suppl. 1): S49-S56.
12. Gurgel RQ, Correia JB, Cuevas LE. Effect of rotavirus vaccination on circulating virus strains. Lancet 2008; 371: 301-302.
13. Gurgel RQ, Cuevas LE, Vieira SC et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2007; 13: 1571-1573.
14. Nakagomi T, Cuevas LE, Gurgel RG et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol 2008; 153: 591-593.
15. Patel MM, de Oliveira LH, Bispo AM, Gentsch JR, Parashar UD. Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2008; 14: 863-865.
16. Chen DY, Estes MK, Ramig RF. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope. J Virol 1992; 66: 432-439.